Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

34.92
+0.60501.76%
Volume:85.32K
Turnover:3.06M
Market Cap:43.24M
PE:- -
High:37.25
Open:35.06
Low:34.70
Close:34.31
52wk High:152.22
52wk Low:11.52
Shares:1.24M
Float Shares:1.24M
Volume Ratio:1.06
T/O Rate:6.89%
Dividend:3.85
Dividend Rate:11.02%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Tempus AI Q2 FY26 Swings to GAAP Profit of $5.64 Million; Revenue Rises 22% to $382.5 Million

Reuters
·
Jul 31

Tempus AI Q2 Revenue Slightly Beats Estimates

Reuters
·
Jul 31

Tempus AI Q2 Adj. EPS $(0.04) Beats $(0.14) Estimate, Sales $382.486M Beat $379.743M Estimate

Benzinga Earnings
·
Jul 31

Tempus AI Inc Q2 Income from Operations USD -75.913 Million

THOMSON REUTERS
·
Jul 31

Tempus AI Inc Q2 Adjusted EPS USD -0.04 VS. Ibes Estimate USD -0.14

THOMSON REUTERS
·
Jul 31

tempus AI Inc Class A options imply 6.9% move in share price post-earnings

TIPRANKS
·
Jul 31

Median Technologies Partners with Canon’s Olea Medical to Commercialize Eyonis LCS Lung Cancer Screening Software

Reuters
·
Jul 30

Sløk Flags Systemic Cross-Asset Risks; AI Turmoil Is Just The Starting Point

Analyst Calls
·
Jul 30

More Cracks Appear Inside The AI Bond Market!

AI Industry Frontlines
·
Jul 28

Anthropic Considers Mandatory Stock Trading Plan For All Employees Ahead Of IPO, Breaking Industry Norms

Hong Kong & US IPO Tracker
·
Jul 27

AI Sector Under Massive Valuation Reset: Market Abandons Blind Capex Hype, Focuses On Cash Flow & ROI

Bellwether Stocks Movement
·
Jul 27

SAP CFO: Generic Chatbots Bring Little Profit; Enterprise Process AI Is True Growth Driver

Analyst Calls
·
Jul 24

Tempus AI announces national launch of OneOme pharmacogenomics testing

TIPRANKS
·
Jul 22

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Immunome (IMNM) and Incyte (INCY)

TIPRANKS
·
Jul 22

Analysts Are Neutral on These Healthcare Stocks: Cencora (COR), Avita Medical (RCEL)

TIPRANKS
·
Jul 22

Tempus AI (TEM) Stock May Trade Below Fair Value Despite Mixed Checks

Simply Wall St.
·
Jul 22

Tempus AI: Buy Rating Reaffirmed as Personalis Deal Strengthens MRD Position; $75 Price Target Maintained

TIPRANKS
·
Jul 22

Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring

Benzinga_recent_news
·
Jul 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tempus AI, Inc. Class A (TEM) and 4D Molecular Therapeutics (FDMT)

TIPRANKS
·
Jul 21

AI Bull Run Hits A Crossroads! Wall Street Erupts In Rare Bull-Bear Showdown

AI Industry Frontlines
·
Jul 21